한국간담췌외과학회지 (Annals of Hepato-Biliary-Pancreatic Surgery)

  • 제27권2호
  • /
  • Pages.141-150
  • /
  • 2023
  • /
  • 2508-5778(pISSN)
  • /
  • 2508-5859(eISSN)
한국간담췌외과학회 (The Korean Association of Hepato-Biliary-Pancreatic Surgery)
권호 표지
DOI QR코드

DOI QR Code

Collective review of pancreatic carcinosarcoma, a very rare pancreatic malignancy

  • Mirang Lee (Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine) ;
  • Young Jae Cho (Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine) ;
  • Hye-Sol Jung (Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine) ;
  • Won-Gun Yun (Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine) ;
  • Youngmin Han (Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine) ;
  • Wooil Kwon (Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine) ;
  • Jin-Young Jang (Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine)
  • 투고 : 2022.09.05
  • 심사 : 2022.12.05
  • 발행 : 2023.05.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Pancreatic carcinosarcoma is a very rare malignancy with a poor prognosis. Because of these characteristics, a treatment strategy for it has not been established yet. The aim of this study was to establish a therapeutic strategy for pancreatic carcinosarcoma. We reviewed data of a 65-year-old female patient who was diagnosed with pancreatic carcinosarcoma through endoscopic ultrasound-guided fine needle aspiration biopsy before surgery. For literature review, we searched PubMed using terms of "Pancreatic" or "Pancreas" and "carcinosarcoma" or "carcinosarcomatous". The patient received 11 cycles of neoadjuvant treatment with leucovorin, fluorouracil, irinotecan, oxaliplatin and pembrolizumab because the tumor was borderline resectable. She underwent stereotactic ablative body radiotherapy (SABR) with 35 Gy in 5 fractions, followed by robotic pylorus-preserving pancreaticoduodenectomy. After surgery, the patient received adjuvant chemotherapy in the same regimen as before surgery. She is alive without any recurrence. Among 48 patients within 33 available papers, the median survival time was 15 months. The survival rate of patients who received adjuvant chemotherapy tended to be higher than that of those who did not receive adjuvant chemotherapy, although the difference was not statistically significant (median survival, 47 vs. 15 months; p = 0.485). Three patients who received neoadjuvant chemotherapy had a survival period of 13-23.5 months. Surgery with lymphadenectomy, adjuvant therapy, and neoadjuvant therapy are thought to help improve survival outcomes. Modern treatment approaches for conventional pancreatic ductal adenocarcinoma could be applied to pancreatic carcinosarcoma.

키워드

참고문헌

  1. Kimura T, Fujimoto D, Togawa T, Ishida M, Iida A, Sato Y, et al. Sarcomatoid carcinoma of the pancreas with rare long-term survival: a case report. World J Surg Oncol 2020;18:105. 
  2. Alhatem A, Quinn PL, Xia W, Chokshi RJ. Pancreatic carcinosarcoma clinical outcome analysis of the National Cancer Institute database. J Surg Res 2021;259:62-70.  https://doi.org/10.1016/j.jss.2020.11.033
  3. Li J, Wei T, Zhang J, Wei S, Chen Q, Chen BW, et al. Carcinosarcoma of the pancreas: comprehensive clinicopathological and molecular characterization. HPB (Oxford) 2020;22:1590-1595.  https://doi.org/10.1016/j.hpb.2020.01.017
  4. Bai Q, Zhang X, Zhu X, Wang L, Huang D, Cai X, et al. Pancreatic carcinosarcoma with the same KRAS gene mutation in both carcinomatous and sarcomatous components: molecular evidence for monoclonal origin of the tumour. Histopathology 2016;69:393-405.  https://doi.org/10.1111/his.12975
  5. Zhu WY, Liu TG, Zhu H. Long-term recurrence-free survival in a patient with pancreatic carcinosarcoma: a case report with a literature review. Med Oncol 2012;29:140-143.  https://doi.org/10.1007/s12032-010-9804-9
  6. Gelos M, Behringer D, Philippou S, Mann B. Pancreatic carcinosarcoma. Case report of multimodal therapy and review of the literature. JOP 2008;9:50-55. 
  7. Jia Z, Zhang K, Huang R, Zhou X, Jiang L. Pancreatic carcinosarcoma with rare long-term survival: case report and review of the literature. Medicine (Baltimore) 2017;96:e5966. 
  8. Lalonde CS, Wang L, Quigley B, Patel P, Maithel SK, El-Rayes BF, et al. Neoadjuvant treatment of pancreatic carcinosarcoma: a case report and review of literature. Chin Clin Oncol 2022;11:8. 
  9. Khan J, Cheng L, House MG, Guo S. Carcinosarcoma, a rare malignant neoplasm of the pancreas. Curr Oncol 2021;28:5295-5303.  https://doi.org/10.3390/curroncol28060442
  10. Quinn PL, Ohioma D, Jones AMK, Ahlawat SK, Chokshi RJ. Treatment of rare and aggressive pancreatic carcinosarcoma. ACG Case Rep J 2020;7:e00379. Erratum in: ACG Case Rep J 2020;7:e00435. 
  11. Zhou DK, Gao BQ, Zhang W, Qian XH, Ying LX, Wang WL. Sarcomatoid carcinoma of the pancreas: a case report. World J Clin Cases 2019;7:236-241.  https://doi.org/10.12998/wjcc.v7.i2.236
  12. Cheng L, Liu Y, Lou C, Cheng L. A case of pancreatic carcinosarcoma detected on PET/CT. Hell J Nucl Med 2021;24:262-264. 
  13. Liu Y, Hao H, Guo X, Xu J, Kang L, Zheng G, et al. Rare pancreatic carcinosarcoma in a patient with medical history of esophageal cancer: a case report and literature review. Medicine (Baltimore) 2019;98:e15238. 
  14. Zhou X, Li M, Wang P, Teng X, Sun L, Chen J, et al. Carcinosarcoma colliding osteosarcoma of the pancreas: a rare case report of multiple clonal originated pancreatic tumors. Int J Clin Exp Pathol 2018;11:1746-1753. 
  15. Still SA, Becerra CR, Clement-Kruzel SE, Cavaness KM. Locally advanced carcinosarcoma of the pancreas. Proc (Bayl Univ Med Cent) 2018;31:210-212.  https://doi.org/10.1080/08998280.2018.1444302
  16. Ruess DA, Kayser C, Neubauer J, Fichtner-Feigl S, Hopt UT, Wittel UA. Carcinosarcoma of the pancreas: case report with comprehensive literature review. Pancreas 2017;46:1225-1233.  https://doi.org/10.1097/MPA.0000000000000904
  17. Salibay CJ, Rewerska J, Gupta S, Ree N. Primary carcinosarcoma of the pancreas with CD10-positive sarcoma component. J Investig Med High Impact Case Rep 2017;5:2324709617740906. 
  18. Mszyco S, Teng L, Annunziata J, Hartman MS. Pancreatic carcinosarcoma: a case report highlighting computed tomography characteristics. Curr Probl Diagn Radiol 2017;46:342-345.  https://doi.org/10.1067/j.cpradiol.2017.01.007
  19. Li BQ, Liu QF, Chang XY, Hu Y, Chen J, Guo JC. Pancreatic carcinosarcoma mimics malignant intraductal papillary mucinous neoplasm: a rare case report and literature review. Medicine (Baltimore) 2017;96:e6961. 
  20. Lee J, Hyun JJ, Lee HS. A rare cause of abdominal pain by pancreatic mass in a young female patient. Carcinosarcoma of the pancreas. Gastroenterology 2015;149:e3-e5.  https://doi.org/10.1053/j.gastro.2014.12.051
  21. Shi HY, Xie J, Miao F. Pancreatic carcinosarcoma: first literature report on computed tomography imaging. World J Gastroenterol 2015;21:1357-1361.  https://doi.org/10.3748/wjg.v21.i4.1357
  22. Oymaci E, Argon A, Coskun A, Ucar AD, Carti E, Erkan N, et al. Pancreatic carcinosarcoma: case report of a rare type of pancreatic neoplasia. JOP 2013;14:212-215. 
  23. Kim HS, Joo SH, Yang DM, Lee SH, Choi SH, Lim SJ. Carcinosarcoma of the pancreas: a unique case with emphasis on metaplastic transformation and the presence of undifferentiated pleomorphic high-grade sarcoma. J Gastrointestin Liver Dis 2011;20:197-200. 
  24. Shen ZL, Wang S, Ye YJ, Wang YL, Sun KK, Yang XD, et al. Carcinosarcoma of pancreas with liver metastasis combined with gastrointestinal stromal tumour of the stomach: is there a good prognosis with the complete resection? Eur J Cancer Care (Engl) 2010;19:118-123.  https://doi.org/10.1111/j.1365-2354.2008.00977.x
  25. Okamura J, Sekine S, Nara S, Ojima H, Shimada K, Kanai Y, et al. Intraductal carcinosarcoma with a heterologous mesenchymal component originating in intraductal papillary-mucinous carcinoma (IPMC) of the pancreas with both carcinoma and osteosarcoma cells arising from IPMC cells. J Clin Pathol 2010;63:266-269.  https://doi.org/10.1136/jcp.2009.071613
  26. Nakano T, Sonobe H, Usui T, Yamanaka K, Ishizuka T, Nishimura E, et al. Immunohistochemistry and K-ras sequence of pancreatic carcinosarcoma. Pathol Int 2008;58:672-677.  https://doi.org/10.1111/j.1440-1827.2008.02289.x
  27. Bloomston M, Chanona-Vilchis J, Ellison EC, Ramirez NC, Frankel WL. Carcinosarcoma of the pancreas arising in a mucinous cystic neoplasm. Am Surg 2006;72:351-355.  https://doi.org/10.1177/000313480607200416
  28. Chmiel B, Wodolazski A, Kozaczka A. [Carcinosarcoma of the pancreas--case report and literature review]. Wiad Lek 2005;58:243-246. Polish. 
  29. Barkatullah SA, Deziel DJ, Jakate SM, Kluskens L, Komanduri S. Pancreatic carcinosarcoma with unique triphasic histological pattern. Pancreas 2005;31:291-292.  https://doi.org/10.1097/01.mpa.0000178283.96276.8a
  30. Yamazaki K. A unique pancreatic ductal adenocarcinoma with carcinosarcomatous histology, immunohistochemical distribution of hCG-beta, and the elevation of serum alpha-feto-protein. J Submicrosc Cytol Pathol 2003;35:343-349. 
  31. Darvishian F, Sullivan J, Teichberg S, Basham K. Carcinosarcoma of the pancreas: a case report and review of the literature. Arch Pathol Lab Med 2002;126:1114-1117.  https://doi.org/10.5858/2002-126-1114-COTP
  32. Watanabe M, Miura H, Inoue H, Uzuki M, Noda Y, Fujita N, et al. Mixed osteoclastic/pleomorphic-type giant cell tumor of the pancreas with ductal adenocarcinoma: histochemical and immunohistochemical study with review of the literature. Pancreas 1997;15:201-208.  https://doi.org/10.1097/00006676-199708000-00013
  33. Millis JM, Chang B, Zinner MJ, Barsky SH. Malignant mixed tumor (carcinosarcoma) of the pancreas: a case report supporting organ-induced differentiation of malignancy. Surgery 1994;115:132-137. 
  34. Takahashi K, Wakayama M, Asaji A, Ando M, Shibuya K, Shibuya H, et al. [An autopsy case of a so-called carcinosarcoma of the pancreas]. Gan No Rinsho 1987;33:1481-1487. Japanese. 
  35. Van Damme J, Snoeks T. [Carcinosarcoma of the body of the pancreas]. Acta Gastroenterol Belg 1951;14:106-113. Belgian. 
  36. Almond LM, Warfield AT, Desai A, Gourevitch D, Ford SJ. Biphasic malignant tumours of the abdominal cavity. Int J Clin Oncol 2017;22:635-640.  https://doi.org/10.1007/s10147-017-1153-7
  37. Strobel O, Lorenz P, Hinz U, Gaida M, Konig AK, Hank T, et al. Actual five-year survival after upfront resection for pancreatic ductal adenocarcinoma: who beats the odds? Ann Surg 2022;275:962-971.  https://doi.org/10.1097/SLA.0000000000004147
  38. Singh R. Review literature on uterine carcinosarcoma. J Cancer Res Ther 2014;10:461-468.  https://doi.org/10.4103/0973-1482.138197
  39. Matsuo K, Takazawa Y, Ross MS, Elishaev E, Podzielinski I, Yunokawa M, et al. Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma. Ann Oncol 2016;27:1257-1266.  https://doi.org/10.1093/annonc/mdw161
  40. Loh TL, Tomlinson J, Chin R, Eslick GD. Cutaneous carcinosarcoma with metastasis to the parotid gland. Case Rep Otolaryngol 2014;2014:173235.